Marlborough, Massachusetts-based pharma company Sunovion will use the Empatica Embrace, a wearable device for seizure detection, in a phase 4 clinical study of Aption, a drug meant to reduce seizures in people with epilepsy.
Sunovion taps Empatica for Phase 4 drug trial and two other digital health projects targeting epilepsy
Insight Sciences 